PAKOLA STEVE (Chief Medical Officer) received a stock award from REGENXBIO INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 1/8/2026ACC: 0001700659-26-000004
Officer· Chief Medical Officer
Since Apr 2019
+101.25K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
101.25K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+65.85K
Price / share
—
Trade value
—
% of position
34.2%
1/6/2026
192.47K→258.32K
Total
Net shares
+65.85K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/6/2026 | A · Award | +65.85K | — | — | 34.2% | 192.47K | 258.32K |
| Total | +65.85K | $0.00 | ||||||
Derivative Transactions1
Stock Options (Right to buy)
Direct
Converts to
Common Stock
35.40K shares
Shares
+35.40K
Strike price
14.18
Held after
35.40K
Exercisable
—
1/6/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Options (Right to buy) Direct | Common Stock35.40K shares | 1/6/2026 | A · Award | +35.40K | 14.18 | — | 35.40K |